Press Release
Business

Antiviral Therapeutics Market 2014-2024 Key Player, Demand, Growth, Opportunities and Forecast

A new market research report on the Global Antiviral Therapeutics market has introduced by KD Market Insights. The report is dedicated to in-depth industry analysis of the global Antiviral Therapeutics market. The Global Antiviral Therapeutics  analysis is broken down on different segmentation levels Including market By Type, By Drug Type, By Distribution Channel.

The antiviral therapeutics market is anticipated to flourish at a CAGR of 5.8% over the forecast period i.e. 2019-2024. Further, the market for antiviral therapeutics was valued at USD XXX.X million in 2018.

Get Report Sample Copy @ https://www.kdmarketinsights.com/sample/5404
 
Rising prevalence of HIV and hepatitis C infections across the globe is resulting in increased demand for antiviral therapeutics. According to the World Health Organization, in 2018, 37.9 Million were living with HIV in the world. Further, according to another WHO report, an estimated 71 million people are suffering from chronic hepatitis C virus infection. Antiviral drugs can treat more than 95% of hepatitis C patients. However, lack of access to diagnosis and treatment is resulting in low treatment ratio. Further, various healthcare organizations and governments are working on reducing the death rate and providing healthcare access to people. This factor is anticipated to strengthen the growth of global antiviral therapeutics market during the forecast period.

Launch of New Drugs
Various leading pharmaceutical companies are focusing on the introduction of new and effective drugs in the market. Furthermore, upcoming patent expiry of few drugs is anticipated to increase the flow of generic drugs in the market. These factors are envisioned to bolster the growth of antiviral therapeutics market.

Barriers – Antiviral Therapeutics Market
High Cost of Therapeutic Treatment
Factors such as high cost of antiviral drug treatment are hindering the growth of global antiviral therapeutics. Moreover, the growing use of natural products and the high cost of developing drugs is also acting as a restraint for global antiviral therapeutics market.

Segmentation Analysis
The antiviral therapeutics market by type is segmented into generic and branded. The market for generic captured the highest percentage in 2018. Moreover, it is anticipated to continue its dominance during the forecast period. In drug type segment, HIV antiviral drugs segment is anticipated to capture the largest percentage share of the market.

Further, global antiviral therapeutics market is also segmented by distribution channel into hospital pharmacy, retail pharmacy store, and online pharmacy. Retail pharmacy segment captured high market share during the forecast period. However, online pharmacy is anticipated to witness the highest growth in the upcoming years. Factors such as increasing penetration of internet and rising online pharmacies across the world are anticipated to bolster the growth of antiviral drugs online retailing market.

Geographical Analysis
Geographically, the report offers an analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In the antiviral therapeutics market, North America accounted for the largest percentage of the market in global antiviral therapeutics market. Increasing prevalence of HIV infections and hepatitis C in North America is anticipated to further drive the growth of North America antiviral therapeutics market. According to U.S. Department of Health & Human Services, about 1.1 million people were living with HIV in 2017. Moreover, around 38,700 new patients were diagnosed in 2016. This factor is anticipated to pave the way for the growth of North America antiviral therapeutics market. Asia Pacific antiviral therapeutics market is anticipated to witness robust growth during the forecast period. Increasing base of the target population and the rising presence of leading pharmaceutical companies is anticipated to impel the growth of Asia Pacific antiviral therapeutics market.

Competitive Landscape
The report profiles various major market players such as
– AbbVie Inc.
– Bristol-Meyrs Squibb Company
– Cipla Inc.
– F. Hoffmann-La Roche Ltd
– Gilead Sciences Inc
– GlaxoSmithKline Plc
– Johnson & Johnson
– Merck & Co. Inc.
– Pfizer Inc.
– Sanofi
– Other Major & Niche Players

Access Complete Research Report with TOC @ https://www.kdmarketinsights.com/product/antiviral-therapeutics-market

Table of Content

1. Preface
1.1. Research Methodology
1.2. Geographic Scope
1.3. Years Considered
2. Executive Summary
3. Market Overview
3.1. Antiviral Therapeutics Overview
3.2. Market Definition & Key Market Segments
3.3. Industry Development
3.4. Global Market Maturity
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
3.5. Porter’s Five Force Analysis
3.6. Industry Value Chain Analysis
3.7. Macro-Economic Trends
4. Competitive Landscape
4.1. Global Antiviral Therapeutics Market 2018
4.2. Global Antiviral Therapeutics Market Value Share, By Company 2018
4.3. Global Antiviral Therapeutics Market Volume Share, By Company 2018
5. Growth Drivers & Barriers in Global Antiviral Therapeutics Market
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Rest of World
6. Trends in Global Antiviral Therapeutics Market
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Rest of World
7. Global Antiviral Therapeutics Market
7.1. Introduction
7.2. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

8. Global Antiviral Therapeutics Market Segmentation Analysis, By Type
8.1. Introduction
8.2. Strategic Insights
8.2.1. BPS Analysis, By Type
8.2.2. Market Attractiveness, By Type
8.3. Generic
8.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
8.4. Branded
8.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

9. Global Antiviral Therapeutics Market Segmentation Analysis, By Drug Type
9.1. Introduction
9.2. Strategic Insights
9.2.1. BPS Analysis, By Drug Type
9.2.2. Market Attractiveness, By Drug Type
9.3. Herpes Antiviral Drugs
9.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
9.4. Hepatitis Antiviral Drugs
9.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
9.5. HIV Antiviral Drugs
9.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
9.6. Influenza Antiviral Drugs
9.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
9.7. Others Antiviral Drugs
9.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

10. Global Antiviral Therapeutics Market Segmentation Analysis, By Mechanism of Action
10.1. Introduction
10.2. Strategic Insights
10.2.1. BPS Analysis, By Mechanism of Action
10.2.2. Market Attractiveness, By Mechanism of Action
10.3. Nucleotide Polymerase Inhibitor
10.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
10.4. Reverse Transcriptase Inhibitor
10.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
10.5. Protease Inhibitor
10.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

11. Global Antiviral Therapeutics Market Segmentation Analysis, By Distribution Channel
11.1. Introduction
11.2. Strategic Insights
11.2.1. BPS Analysis, By Distribution Channel
11.2.2. Market Attractiveness, By Distribution Channel
11.3. Hospital Pharmacy Store
11.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
11.4. Retail Pharmacy Store
11.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
11.5. Online Pharmacy
11.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12. Geographical Analysis
12.1. Introduction
12.2. North America Antiviral Therapeutics Market
12.2.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.2. By Type
12.2.2.1. Introduction
12.2.2.2. Strategic Insights
12.2.2.2.1. BPS Analysis, By Type
12.2.2.2.2. Market Attractiveness, By Type
12.2.2.3. Generic
12.2.2.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.2.4. Branded
12.2.2.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.3. By Drug Type
12.2.3.1. Introduction
12.2.3.2. Strategic Insights
12.2.3.2.1. BPS Analysis, By Drug Type
12.2.3.2.2. Market Attractiveness, By Drug Type
12.2.3.3. Herpes Antiviral Drugs
12.2.3.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.3.4. Hepatitis Antiviral Drugs
12.2.3.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.3.5. HIV Antiviral Drugs
12.2.3.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.3.6. Influenza Antiviral Drugs
12.2.3.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.3.7. Others Antiviral Drugs
12.2.3.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.4. By Mechanism of Action
12.2.4.1. Introduction

12.2.4.2. Strategic Insights
12.2.4.2.1. BPS Analysis, By Mechanism of Action
12.2.4.2.2. Market Attractiveness, By Mechanism of Action
12.2.4.3. Nucleotide Polymerase Inhibitor
12.2.4.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.4.4. Reverse Transcriptase Inhibitor
12.2.4.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.4.5. Protease Inhibitor
12.2.4.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.5. By Distribution Channel
12.2.5.1. Introduction
12.2.5.2. Strategic Insights
12.2.5.2.1. BPS Analysis, By Distribution Channel
12.2.5.2.2. Market Attractiveness, By Distribution Channel
12.2.5.3. Hospital Pharmacy Store
12.2.5.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.5.4. Retail Pharmacy Store
12.2.5.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.5.5. Online Pharmacy
12.2.5.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.6. By Country
12.2.6.1. Introduction
12.2.6.2. Strategic Insights
12.2.6.2.1. BPS Analysis, By Country
12.2.6.2.2. Market Attractiveness, By Country
12.2.6.3. U.S. Antiviral Therapeutics Market
12.2.6.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.2.6.4. Canada Antiviral Therapeutics Market
12.2.6.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3. Europe Antiviral Therapeutics Market
12.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.2. By Type
12.3.2.1. Introduction
12.3.2.2. Strategic Insights
12.3.2.2.1. BPS Analysis, By Type
12.3.2.2.2. Market Attractiveness, By Type
12.3.2.3. Generic
12.3.2.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.2.4. Branded
12.3.2.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.3. By Drug Type

12.3.3.1. Introduction
12.3.3.2. Strategic Insights
12.3.3.2.1. BPS Analysis, By Drug Type
12.3.3.2.2. Market Attractiveness, By Drug Type
12.3.3.3. Herpes Antiviral Drugs
12.3.3.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.3.4. Hepatitis Antiviral Drugs
12.3.3.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.3.5. HIV Antiviral Drugs
12.3.3.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.3.6. Influenza Antiviral Drugs
12.3.3.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.3.7. Others Antiviral Drugs
12.3.3.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.4. By Mechanism of Action
12.3.4.1. Introduction
12.3.4.2. Strategic Insights
12.3.4.2.1. BPS Analysis, By Mechanism of Action
12.3.4.2.2. Market Attractiveness, By Mechanism of Action
12.3.4.3. Nucleotide Polymerase Inhibitor
12.3.4.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.4.4. Reverse Transcriptase Inhibitor
12.3.4.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.4.5. Protease Inhibitor
12.3.4.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024
12.3.5. By Distribution Channel

Continue @…
 
Check for Discount @ https://www.kdmarketinsights.com/discount/5404
 
About Us:
 
KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.
 
Contact Us:
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: [email protected]
Website: www.kdmarketinsights.com
https://marketreserachtab.blogspot.com/
http://kdmarketinsights.blogspot.com/